Report of a National Conference on Donation after cardiac death.

PubWeight™: 3.04‹?› | Rank: Top 1%

🔗 View Article (PMID 16426312)

Published in Am J Transplant on February 01, 2006

Authors

J L Bernat, A M D'Alessandro, F K Port, T P Bleck, S O Heard, J Medina, S H Rosenbaum, M A Devita, R S Gaston, R M Merion, M L Barr, W H Marks, H Nathan, K O'connor, D L Rudow, A B Leichtman, P Schwab, N L Ascher, R A Metzger, V Mc Bride, W Graham, D Wagner, J Warren, F L Delmonico

Articles citing this

Declining liver utilization for transplantation in the United States and the impact of donation after cardiac death. Liver Transpl (2013) 2.07

Donation after cardiac death as a strategy to increase deceased donor liver availability. Ann Surg (2006) 1.66

Epidemiology of death in the PICU at five U.S. teaching hospitals*. Crit Care Med (2014) 1.62

The concept of death and deceased organ donation. Int J Organ Transplant Med (2010) 1.45

Lung Quality and Utilization in Controlled Donation After Circulatory Determination of Death Within the United States. Am J Transplant (2016) 1.42

Recovery of transplantable organs after cardiac or circulatory death: transforming the paradigm for the ethics of organ donation. Philos Ethics Humanit Med (2007) 1.27

Donation after cardiac death: a 29-year experience. Surgery (2011) 1.18

Controversies in defining and determining death in critical care. Nat Rev Neurol (2013) 1.08

Brain death, cardiac death, and the dead donor rule. J S C Med Assoc (2011) 1.07

Use of extended criteria livers decreases wait time for liver transplantation without adversely impacting posttransplant survival. Ann Surg (2006) 1.06

Donation after cardiocirculatory death: a call for a moratorium pending full public disclosure and fully informed consent. Philos Ethics Humanit Med (2011) 1.00

Organ donation after circulatory death: the forgotten donor? Crit Care (2006) 0.99

Should we allow organ donation euthanasia? Alternatives for maximizing the number and quality of organs for transplantation. Bioethics (2010) 0.99

Challenges of organ shortage for transplantation: solutions and opportunities. Int J Organ Transplant Med (2014) 0.98

The United States Revised Uniform Anatomical Gift Act (2006): new challenges to balancing patient rights and physician responsibilities. Philos Ethics Humanit Med (2007) 0.97

The faltering solid organ donor pool in the United States (2001-2010). World J Surg (2012) 0.95

Islam and end-of-life practices in organ donation for transplantation: new questions and serious sociocultural consequences. HEC Forum (2009) 0.91

Machine perfusion versus cold storage of kidneys derived from donation after cardiac death: a meta-analysis. PLoS One (2013) 0.84

A collection of primary tissue cultures of tumors from vacuum packed and cooled surgical specimens: a feasibility study. PLoS One (2013) 0.84

Truthfulness in transplantation: non-heart-beating organ donation. Philos Ethics Humanit Med (2007) 0.83

Prediction of survival after liver transplantation for chronic severe hepatitis B based on preoperative prognostic scores: a single center's experience in China. World J Surg (2009) 0.81

Using old liver grafts for liver transplantation: where are the limits? World J Gastroenterol (2014) 0.81

Long-term results using old liver grafts for transplantation: sexagenerian versus liver donors older than 70 years. World J Surg (2013) 0.80

Changing pattern of organ donation and utilization in the USA. Int J Organ Transplant Med (2012) 0.79

The Global role of kidney transplantation. J Nephropathol (2012) 0.79

Organ procurement organizations Internet enrollment for organ donation: abandoning informed consent. BMC Med Ethics (2006) 0.79

Donation after cardio-circulatory death liver transplantation. World J Gastroenterol (2012) 0.78

Ethics review: dark angels--the problem of death in intensive care. Crit Care (2007) 0.78

Kidney and liver transplants from donors after cardiac death: initial experience at the London Health Sciences Centre. Can J Surg (2010) 0.76

Is the Canadian health care system ready for donation after cardiac death? A note of caution. CMAJ (2006) 0.76

The global role of kidney transplantation. Indian J Nephrol (2012) 0.75

Effects of 10 Hz Repetitive Transcranial Magnetic Stimulation of the Left Dorsolateral Prefrontal Cortex in Disorders of Consciousness. Front Neurol (2017) 0.75

Donation after brain circulation determination of death. BMC Med Ethics (2017) 0.75

Donor gluconate rescues livers from uncontrolled donation after cardiac death. Surgery (2015) 0.75

The global role of kidney transplantation for the world kidney day steering committee 2012. Int J Organ Transplant Med (2012) 0.75

Challenges and advances in optimizing liver allografts from donation after circulatory death donors. J Nat Sci Biol Med (2016) 0.75

Which time is it? A suggestion for unambiguous nomenclature in transplantation. Am J Transplant (2007) 0.75

Anesthesia for liver transplantation from a maastricht category 4 non-heart-beating donor -A case report-. Korean J Anesthesiol (2010) 0.75

Evaluating the Effect of Repetitive Transcranial Magnetic Stimulation on Disorders of Consciousness by Using TMS-EEG. Front Neurosci (2016) 0.75

Pro/con debate: in patients who are potential candidates for organ donation after cardiac death, starting medications and/or interventions for the sole purpose of making the organs more viable is an acceptable practice. Crit Care (2007) 0.75

Simultaneous liver and kidney transplantation using donation after cardiac death donors: a brief report. Liver Transpl (2011) 0.75

Consequences of the Dead Donor Rule. Ann Thorac Surg (2014) 0.75

Transplantation: Can kidneys donated after cardiac death save lives? Nat Rev Nephrol (2010) 0.75

Long term follow-up and outcome of liver transplantation from hepatitis B surface antigen positive donors. World J Gastroenterol (2017) 0.75

Articles by these authors

The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. JAMA (1996) 17.62

Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med (1999) 15.69

Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant (2006) 8.03

Phytochromes: photosensory perception and signal transduction. Science (1995) 7.91

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis (1998) 7.79

Phase II evaluation of clinical coding schemes: completeness, taxonomy, mapping, definitions, and clarity. CPRI Work Group on Codes and Structures. J Am Med Inform Assoc (1997) 7.18

Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science (2000) 6.52

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology (2001) 6.19

A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Engl J Med (1999) 6.08

COP1, an Arabidopsis regulatory gene, encodes a protein with both a zinc-binding motif and a G beta homologous domain. Cell (1992) 5.58

Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol (2001) 4.36

Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat Neurosci (2001) 4.10

Short-term effects of carbon monoxide exposure on the exercise performance of subjects with coronary artery disease. N Engl J Med (1989) 4.02

Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J (2010) 3.81

Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group. Antimicrob Agents Chemother (1994) 3.73

Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med (1989) 3.67

Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts. N Engl J Med (1981) 3.63

THE THERAPEUTIC EFFECTIVENESS OF A PRACTICALLY NONTOXIC NEW COMPOUND (CALCIUM AUROTHIOMALATE) IN EXPERIMENTAL, PROLIFERATIVE, CHRONIC ARTHRITIS OF MICE. Science (1940) 3.63

Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int (2006) 3.58

"Occult" hepatitis B virus as source of infection in liver transplant recipients. Lancet (1994) 3.33

The Curative Effect of Certain Gold Compounds on Experimental Proliferative, Chronic Arthritis in Mice. J Bacteriol (1940) 3.31

Consensus statement on the live organ donor. JAMA (2000) 3.29

Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: an executive summary. Society of Critical Care Medicine. Crit Care Med (1995) 3.19

Anesthesiology. First of two parts. N Engl J Med (1997) 3.16

A PYOGENIC VIRUS IN THE RAT. Science (1938) 3.12

Child hunger in Canada: results of the 1994 National Longitudinal Survey of Children and Youth. CMAJ (2000) 3.08

Delayed graft function: risk factors and implications for renal allograft survival. Transplantation (1997) 3.01

Cardiovascular mortality in children and young adults with end-stage kidney disease. J Pediatr (2002) 2.96

Body mass index and mortality in 'healthier' as compared with 'sicker' haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant (2001) 2.94

Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int (2001) 2.92

Extended preservation of the liver for clinical transplantation. Lancet (1988) 2.89

Survival benefit-based deceased-donor liver allocation. Am J Transplant (2009) 2.89

Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int (2006) 2.85

Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol (2001) 2.80

Anesthesiology. Second of two parts. N Engl J Med (1997) 2.69

The impact of long-term acute-care facilities on the outcome and cost of care for patients undergoing prolonged mechanical ventilation. Crit Care Med (2000) 2.66

Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. Am J Kidney Dis (2000) 2.65

Effect of waiting time on renal transplant outcome. Kidney Int (2000) 2.57

The impact of comorbid and sociodemographic factors on access to renal transplantation. JAMA (1993) 2.54

HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant (2007) 2.50

The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant (2008) 2.48

A Ufd2/D4Cole1e chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration (WldS) mouse. Proc Natl Acad Sci U S A (2000) 2.40

Calculating life years from transplant (LYFT): methods for kidney and kidney-pancreas candidates. Am J Transplant (2008) 2.39

Long-term survival in renal transplant recipients with graft function. Kidney Int (2000) 2.38

Determinants of discard of expanded criteria donor kidneys: impact of biopsy and machine perfusion. Am J Transplant (2008) 2.38

The evaluation of renal transplant candidates: clinical practice guidelines. Patient Care and Education Committee of the American Society of Transplant Physicians. J Am Soc Nephrol (1995) 2.32

Prevalence of Campylobacter spp., Escherichia coli, and Salmonella serovars in retail chicken, turkey, pork, and beef from the Greater Washington, D.C., area. Appl Environ Microbiol (2001) 2.26

Occupational and other exposures associated with male end-stage renal disease: a case/control study. Am J Public Health (1990) 2.26

Requesting organ donation: an interview study of donor and nondonor families. Am J Crit Care (1998) 2.23

Treatment of acute renal allograft rejection with OKT3 monoclonal antibody. Transplantation (1981) 2.22

Immunosuppression: evolution in practice and trends, 1994-2004. Am J Transplant (2006) 2.22

Risk factors for primary dysfunction after liver transplantation--a multivariate analysis. Transplantation (1993) 2.20

Orthotopic liver transplantation: a pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection. Hepatology (1985) 2.18

Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine. Clin Pharmacol Ther (1997) 2.17

Renal transplantation in black Americans. N Engl J Med (2000) 2.17

Noncompliance in hemodialysis: predictors and survival analysis. Am J Kidney Dis (1998) 2.16

Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol (2000) 2.16

Human papillomavirus infections in women with and without abnormal cervical cytology. Lancet (1987) 2.13

Recommendations for end-of-life care in the intensive care unit: The Ethics Committee of the Society of Critical Care Medicine. Crit Care Med (2001) 2.12

Cyclosporine: five years' experience in cadaveric renal transplantation. N Engl J Med (1984) 2.10

Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology (1992) 2.09

Prolonged cold ischemia time obviates the benefits of 0 HLA mismatches in renal transplantation. Arch Surg (2000) 2.09

Database comparison of the adult-to-adult living donor liver transplantation cohort study (A2ALL) and the SRTR U.S. Transplant Registry. Am J Transplant (2010) 2.04

Liver and intestine transplantation in the United States, 1997-2006. Am J Transplant (2008) 2.04

Donation after cardiac death liver transplantation: predictors of outcome. Am J Transplant (2010) 2.02

American Society of Transplant Surgeons transplant center outcomes requirements--a threat to innovation. Am J Transplant (2009) 2.00

Predictors of type of vascular access in hemodialysis patients. JAMA (1996) 2.00

Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am J Transplant (2007) 2.00

Survival advantage in Asian American end-stage renal disease patients. Kidney Int (1999) 1.98

The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant (2011) 1.98

Gastric tonometry and venous oximetry in cardiac surgery patients. Crit Care Med (1991) 1.94

A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. J Urol (2003) 1.93

Mortality after kidney transplantation: a comparison between the United States and Canada. Am J Transplant (2006) 1.92

Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients. Radiology (1993) 1.92

Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation (2000) 1.90

Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol (2000) 1.90

Laboratory models of sepsis and septic shock. J Surg Res (1990) 1.90

In vivo OCT imaging of hard and soft tissue of the oral cavity. Opt Express (1998) 1.89

Multiple subpial transection: a new approach to the surgical treatment of focal epilepsy. J Neurosurg (1989) 1.87

Organ trafficking and transplant tourism: a commentary on the global realities. Am J Transplant (2008) 1.87

Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice. Proc Natl Acad Sci U S A (2006) 1.87

Experience with reduced-size liver transplantation. Surg Gynecol Obstet (1990) 1.87

International practices of organ donation. Br J Anaesth (2012) 1.85

Identification and characterization of integron-mediated antibiotic resistance among Shiga toxin-producing Escherichia coli isolates. Appl Environ Microbiol (2001) 1.82

Enhancement of fluid filtration across tumor vessels: implication for delivery of macromolecules. Proc Natl Acad Sci U S A (1999) 1.82

The dose of hemodialysis and patient mortality. Kidney Int (1996) 1.82

Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology (1995) 1.81

Identification of human papillomavirus in cervical swabs by deoxyribonucleic acid in situ hybridization. Obstet Gynecol (1984) 1.80

Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of peripheral blood stem cells. Biol Blood Marrow Transplant (1997) 1.80

Using transjugular intrahepatic portosystemic shunts to control variceal bleeding before liver transplantation. Ann Intern Med (1992) 1.80

Respiratory changes induced by the large glucose loads of total parenteral nutrition. JAMA (1980) 1.79